September 18, 2023
Patient Reverend Michael Bailey and University of Cincinnati Cancer Center member Nilesh Patil spoke with WCPO about the importance of screening during Prostate Cancer Awareness Month.
May 1, 2024
Yahoo News featured comments from the University of Cincinnati's Rekha Chaudhary in a story about rising rates of diagnoses and deaths from colorectal cancers among young people.
April 15, 2024
The University of Cincinnati's Carla Justiniano spoke with Healthline about colorectal cancer in an article about a woman diagnosed with cancer when she was seven months pregnant.
May 2, 2022
The University of Cincinnati's Alice Tang was featured in a Healio article discussing recently published research that administering an immunotherapy drug prior to surgery did not increase risks for patients with advanced oral cavity cancer.
September 19, 2022
Abhinav Sidana, MD, joined WVXU's Cincinnati Edition to discuss high-intensity focused ultrasound, a new treatment option for patients with prostate cancer.
January 9, 2023
The University of Cincinnati's Carla F. Justiniano, MD, joined 55KRC's Simply Medicine to discuss colon cancer screening and prevention following the death of actor Kirstie Alley.
February 7, 2023
The Cincinnati Enquirer highlighted the University of Cincinnati Cancer Center's efforts to become a National Cancer Institute-designated cancer center.
October 17, 2023
Local 12 highlighted local life coach Krista Powers' breast cancer journey, including the importance of the University of Cincinnati Cancer Center's Oncology Care Clinic that provides primary care designed for patients with a cancer diagnosis.
January 23, 2024
The Cancer Letter highlighted the University of Cincinnati Cancer Center’s Maria Czyzyk-Krzeska's new NIH-funded research that will investigate how copper contributes to the advancement and recurrence of clear cell renal cell carcinoma.
April 7, 2023
Drug Discovery News highlighted research coauthored by the University of Cincinnati's Timothy Phoenix that found a gene called FOXR2 is abnormally expressed in more than 70% of cancer types sampled and could be a potential target for new treatments.